FTRE
Fortrea Holdings Inc.
NASDAQ · Healthcare · Biotechnology · US
$19.93
−1.73%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$20.08
From 52W high−3.72%
Volume3.08M
Market cap$1.90B
P/E (TTM)—
P/S (TTM)0.7x
Div yield—
Key dataSep 18, 2026
Open
$20.08
From 52W high
−3.72%
Volume
3.08M
Market cap
$1.90B
ValuationView details →
P/E (Fwd)
21.1x
EV/EBITDA
35.0x
P/E (TTM)
—
RSI (14)
58.4
MomentumView details →
1D Return
−1.73%
YTD Return
+13.45%
SummaryUpdated Jun 1, 2026
Fortrea Holdings Inc. (NYSE:FTRE) is a contract research organization (CRO) that was spun off from Laboratory Corporation of America Holdings (LabCorp) in July 2023. The company was incorporated in 2023 and is headquartered in Durham, North Carolina. As a newly independent public company, Fortrea provides comprehensive clinical research services to pharmaceutical, biotechnology, and medical device companies worldwide, helping them navigate the complex process of bringing new treatments and medical devices to market.
Similar companies
Latest newsMore news →
Fortrea granted inducement awards of restricted stock units and performance share units to five newly hired employees on September 10, 2026.10d agoFortrea Holdings Inc. appointed Jason Knoblauch as Chief Financial Officer effective September 9, 2026, with David Smith serving as Interim Chief Financial Officer.10d ago